share_log

A股流感概念股涨停个股增加:以岭药业等超10股涨停,新华制药逼近涨停

The number of A-share flu Concept stocks with limit rise increases: Shijiazhuang Yiling Pharmaceutical and more than 10 other stocks hit the limit rise, while Shandong Xinhua Pharmaceutical is nearing the limit rise.

Gelonghui Finance ·  Jan 6 13:19

Gelonghui, January 6 - Currently, it is winter, and the influenza virus is making a comeback, drawing attention to flu medications. In the A-share market, flu Concept stocks have further increased their gains in the afternoon, with more stocks hitting the daily limit. As of now, Sichuan Goldstone has reached the daily limit of 20%, Shanxi Zhendong Pharmaceutical has risen nearly 15%, Xiangxue Pharmaceutical has increased over 11%, Henan Taloph Pharmaceutical Stock, North China Pharmaceutical, Luoxin Pharmaceuticals Group Stock, Xinjiang Bai Hua Cun Pharma Tech, Shandong Lukang Pharmaceutical, Northeast Pharmaceutical Group, Shijiazhuang Yiling Pharmaceutical, Hainan Huluwa Pharmaceutical Group, Harbin Pharmaceutical Group, and Guangdong Zhongsheng Pharmaceutical have all hit the daily limit of 10%, while Shandong Xinhua Pharmaceutical is close to reaching its daily limit.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment